CTKB - Cytek Corp Price to Sales

Corporate company logo of Cytek Corp (CTKB)

Cytek Biosciences, Inc. (CTKB) relies on a proven network of external laser component suppliers to ensure flexible production scaling. However, risks associated with grant reductions and R&D expenditures may pressure margins. The revenue multiple level visualizes market deviations, where 3.50 reflects the metric's baseline. Node assembly and reagent logistics are delegated to contract manufacturers to provide agile customer support.

CTKB - Cytek Bio P/S Multiple over the range 07/04/2022 - 11/13/2026

Cytek Bio (CTKB) - metric breakdowns and financial figures

- market price and analyst price targets:
Stock Quotes cytekbio.com|CTKB - Consensus Target
- market capitalization statistics:
Market Value Cytek Bio|CTKB - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Price of a Share Cytek Biosciences|CTKB - Book Capitalization|Market-to-Book Ratio cytekbio.com|CTKB - Aggregate Company Assets
- business debt structure and liquidity details:
Total Debt to Capital Cytek Biosciences, Inc.|CTKB - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Cytek Corp|CTKB - Company Aggregate Debts|Debt to Book Capitalization Ratio Cytek Bio|CTKB - Company Long-Term Debts|Short-Term Debt Volume Cytek Biosciences|Immediate Liquidity cytekbio.com
- earnings and market ratios statistics:
CTKB - Company Net Income|Company Profit Forecast Cytek Biosciences, Inc.|CTKB - P/E Multiple|Projected Price to Earnings Cytek Biosciences Inc|CTKB - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Cytek Bio|CTKB - Operating profit EBITDA|Net earnings per one share for the last twelve months Cytek Biosciences|CTKB - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months cytekbio.com|CTKB - Earnings growth in current year|Expected earnings per share growth for next year Cytek Biosciences, Inc.
- issuer revenue and sales details:
CTKB - Revenue and Sales Volume|Company Expected Sales Volume cytekbio.com|CTKB - Price-to-Revenue Ratio|Market Cap to Expected Sales Ratio Cytek Bio
General company analysis:cytekbio.com CTKB
Signature product of Cytek Corp

The global humanitarian immunity of Cytek Biosciences (CTKB) biomedical innovations minimizes external risks, creating a stable foundation for revenue capitalization. The price-to-sales ratio measures the premium the market is willing to pay for every dollar of revenue; therefore, volatility in the P/S ratio allows for the timely identification of dangerous asset overvaluation or the market undervaluation of the business's fundamental strength.

Competing companies

Market Cap to Revenue agilent.com A|Quest Diagnostics Incorporated - Market Cap to Revenue|Illumina Inc (ILMN) - Price to Sales|EXAS: Market Cap to Revenue|Revvity Corp - Market Cap to Sales Volume|BIO: P/S Multiple|Price to Sales anbio.com (NNNN)|Price-to-Revenue Ratio Sotera Health|P/S Multiple Quidel Corporation|Market Cap to Revenue OPK (OPKO Corp)|CDNA (CareDx Health) - Market Capitalization-to-Revenue Ratio|P/S Multiple MRVI (Maravai LifeSciences)|fulgentgenetics.com - Price-to-Revenue Ratio|Standard BioTools - P/S Multiple|Price-to-Revenue Coefficient OraSure Technologies, Inc. OSUR|exagen.com (XGN) - Price-to-Revenue Ratio|Price to Sales MDxHealth, Inc. (MDXH)|Price-to-Revenue Ratio Lucid Diagnostics Inc.|Prenetics Global Ltd (PRE) - Price-to-Revenue Coefficient|P/S Multiple IMDX|Market Cap to Revenue trinitybiotech.com TRIB|P/S Multiple PRPH (ProPhase)|Price-to-Revenue Coefficient Ainos Corporation (AIMD)|Co-Diagnostics, Inc. - P/S Multiple|Price to Sales heartsciences.com|Biomerica (BMRA) - Price-to-Revenue Ratio|Market Cap to Revenue Ratio CDIO|ONCO (Onconetix Corp) - P/S Multiple|Market Cap to Revenue Virax Biolabs Corp (VRAX)|P/S Multiple BJDX|AWH - Price to Sales|Price-to-Revenue Ratio Accelerate Diagnostics, Inc. AXDX|Price-to-Revenue Coefficient Centogene N.V. (CNTG)|ENZ: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio FRES (Fresh2 Group Limited)|GENE: P/S Multiple|ME - Price-to-Revenue Coefficient|Price-to-Revenue Ratio Psychemedics Corporation